FIELD: medicine, pharmacy.
SUBSTANCE: invention describes a composition of biologically active components designated for using in therapeutically effective doses for decreasing the concentration of plasma lipoprotein in mammals. The composition consists of the following substances or their pharmaceutically acceptable salts: ascorbic acid, ascorbyl palmitate, beta-, gamma- and delta-tocopherols in mixture, beta-carotene, biotin, calcium ascorbinate, calcium glycinate, carotinoids in mixture (α-carotene, lutein, zea-cryproxanthine), cholecalciferol, chrome glycinate, citrus bioflavonoids, coenzyme Q10, copper glycinate, cyanocobalamine, d-alpha-tocopherol, calcium d-pantothenate, dicalcium phosphate, folic acid, inositol, L-arginine, L-carnitine, L-cysteine, L-lysine, L-proline, L-selenomethionine, magnesium ascorbinate, magnesium glycinate, manganese chelate, molybdenum glycinate, niacin, niacinamide, potassium chelate, picnogenol, pyridoxine, riboflavin, thiamine and zinc glycinate. Proposed composition is used in treatment of humans with different diseases being among them against heart ischemic diseases, arteriosclerosis, brain vascular diseases and others.
EFFECT: improved, enhanced and valuable medicinal properties of composition.
6 cl, 1 tbl, 2 dwg, 2 ex
